Ginolis Ltd. has delivered a development and production solution for point-of- care diagnostic tests to a Canada-based company that is operating in international markets.
The tests are used for assessing cardiac risks and are already available internationally.
The Ginolis solution provides increased production capacity and improved quality control with which the customer can respond to market demands. The solution is based on the modular Ginolis Delilah system.
“This deal is a major opener for us in the Canadian and North-West Americas markets,” says Matti Koivu, Ginolis vice resident, business development.